Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Pacertool develops PaCRTool, a solution to improve cardiac resynchronization therapy (CRT) in heart failure patients.
Quibim is using artificial intelligence to unlock new insights from medical images.
Protembis is developing the ProtEmbo Cerebral Protection System.
The company's product is a next-generation beta ophthalmic applicator.
RevBio is using tetranite, a unique organic compound, as the base for its platform of bone adhesive biomaterials.
Robopedics' Awake is a robotic orthopedic solution specifically for stroke victims.
SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue.
Sensome is developing an innovative remote and non-invasive monitoring system for implantable medical devices allowing the characterization of the tissue surrounding the device.
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants.
TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.
Xenter is focused on developing new wireless medical device and giital technologies for interventional cardiology, radiology, and neurointerventional radiology.
The company is developing a portable, non-invasive, and affordable solution to bring early cancer detection into the community clinic and general practitioners offices.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures.
Vascular Perfusion Solutions specializes in the development of technologies to enhance the preservation of organs.
UpSurgeOn's mission is to fill the gap between theory and practice in surgery via psychomotor skill augmentation.
SmartWound allows objective diagnosis of the Critical Infection Threshold in under 15 minutes and can therefore differentiate patients with infected wounds from those without an infection.
Sonic Incytes' Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types.
TendoMend's Dynamic Tendon Grip surgical device that replaces the traditional, time-consuming techniques currently used for the repair of ruptured tendons.
CloverLife is addressing some of the largest challenges in the increasing population of patients suffering from heart valve disease.
earAccess strives to improve access to high-quality, cost-effective hearing aids.
Haermonics has developed a novel drainage system to prevent complications in postoperative open-heart surgery patients.
OrthoSon's minimally invasive, motion-restoring treatment is being developed as an alternative to spinal fusion for the treatment of degenerated discs.
RECORNEA's GROSSO implant restores the physiological curvature of the cornea and halts progression of the disease, Keratoconus.
SharpView Ophthalmology is committed to developing medical technologies in the field of ocular implants for macular disorders.
Senseye is building a platform to support patients in managing their mental health.
Rob Surgical is developing a surgical robotic system for minimally invasive surgery.
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients.
Edwards Lifesciences specializes in artificial heart valves and hemodynamic monitoring.
